On 27 May 2026, Verge Labs, formerly Verge Genomi
Author: Michael
Ribo has submitted a Phase 2 clinical trial appli
Avaí Bio and Austrianova’s Nevada joint ventur
SynuSight Biotech announced a collaborative study
BioCardia reported that Japan’s Pharmaceutical
ABILITY Neurotech wins approval for the first lo
California-based startup bets on AI-designed bio
ArentFox Schiff’s Gayland Hethcoat on navigati
Multimillion-dollar collaboration shifts the len
Insilico Medicine and Human Life Foundation Model